We Save You Time and Resources By Curating Relevant Information and News About Anecdotal Evidence and Stories.

Spread the love

How is Anecdotal Evidence a Benefit to Scientists?

People are benefiting from all sorts of natural cures to various health problems by trying various methods that have not been verified by the scientific method. They share these stories in person and anecdotally using social media and other online forums.  Do these anecdotes help scientists in any way?

Do Scientists Use Anecdotal Evidence to Develop Hypothesis for their Studies?

People have been benefiting from ketogenic diets even when science hasn’t yet proven any benefit to a ketogenic diet. The Anecdotal reports from patients who are using ketogenic nutrition to treat Alzheimer’s, Parkinson’s, and some cancers are leading scientists to perform specific research into ketogenic nutrition and its benefits. The Alzheimer’s Association funded animal research and a human trial in Dr. Dominick D’Agostino’s lab to try to get answers and determine if ketogenic diets help treat Alzheimer’s.

Who is Dr. Dominick D’ Agostino?

You can read more about Dr. D’Agostino here https://ketonutrition.org/about/.


Where can I learn more about Ketogenic Diets?

You can learn more about the keto diet at https://charliefoundation.org/. Subscribe to the Charlie Foundation YouTube channel at https://www.youtube.com/channel/UCYdGA_RvciUpOb4gNaohRSQ.

Video Transcript

There are people who are experiencing the benefits of this ketogenic diet without clinical trials being in place because they recognize the preclinical animal model work is compelling and there are people for example with Alzheimer’s disease or Huntington’s disease or Parkinson’s disease or different types of cancers where the clinical trials have not been done yet. But they have exhausted all options for therapies and they don’t have anything to lose so many of these patients implement a ketogenic approach.
For example, Mary Newport and her husband Steve and that observation and the documentation of him improving with a mild ketogenic therapy motivated the Alzheimer’s Association to fund an animal study in our lab and our colleague’s lab and ultimately a clinical trial. So these anecdotal reports can become very compelling and very powerful for moving not only the science forward but also the clinical trials.